Search

Author/Creator Press, Michael F.

1. Randomized phase II study of fulvestrant and erlotinib compared with erlotinib alone in patients with advanced or metastatic non-small cell lung cancer. (September 2018)

Authors:
Garon, Edward B.; Siegfried, Jill M.; Stabile, Laura P.; Young, Patricia A.; Marquez-Garban, Diana C.; Park, David J.; Patel, Ravi; Hu, Eddie H.; Sadeghi, Saeed; Parikh, Rupesh J.; Reckamp, Karen L.; Adams, Brad; Elashoff, Robert M.; Elashoff, David; Grogan, Tristan; Wang, He-Jing; Dacic, Sanja; ...
Journal:
Lung cancer
Issue:
Volume 123(2018)
Page Start:
91
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Phase III, Randomized Study of Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade With Lapatinib Plus Trastuzumab in Combination With an Aromatase Inhibitor in Postmenopausal Women With HER2-Positive, Hormone Receptor–Positive Metastatic Breast Cancer: Updated Results of ALTERNATIVE. Issue 1 (1st January 2021)

Authors:
Johnston, Stephen R. D.; Hegg, Roberto; Im, Seock-Ah; Park, In Hae; Burdaeva, Olga; Kurteva, Galina; Press, Michael F.; Tjulandin, Sergei; Iwata, Hiroji; Simon, Sergio D.; Kenny, Sarah; Sarp, Severine; Izquierdo, Miguel A.; Williams, Lisa S.; Gradishar, William J.
Journal:
Journal of clinical oncology
Issue:
Volume 39:Issue 1(2021)
Page Start:
79
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Reduced risk of breast cancer associated with recreational physical activity varies by HER2 status. (27th April 2015)

Authors:
Ma, Huiyan; Xu, Xinxin; Ursin, Giske; Simon, Michael S.; Marchbanks, Polly A.; Malone, Kathleen E.; Lu, Yani; McDonald, Jill A.; Folger, Suzanne G.; Weiss, Linda K.; Sullivan‐Halley, Jane; Deapen, Dennis M.; Press, Michael F.; Bernstein, Leslie
Journal:
Cancer medicine
Issue:
Volume 4:Number 7(2015:Jul.)
Page Start:
1122
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. A Standardized Investigational Ki-67 Immunohistochemistry Assay Used to Assess High-Risk Early Breast Cancer Patients in the monarchE Phase 3 Clinical Study Identifies a Population With Greater Risk of Disease Recurrence When Treated With Endocrine Therapy Alone. Issue 4 (25th April 2022)

Authors:
Polewski, Monika D.; Nielsen, Gitte B.; Gu, Ying; Weaver, Aaron T.; Gegg, Gavin; Tabuena-Frolli, Siena; Cajaiba, Mariana; Hanks, Debra; Method, Michael; Press, Michael F.; Gottstein, Claudia; Gruver, Aaron M.
Journal:
Applied immunohistochemistry & molecular morphology
Issue:
Volume 30:Issue 4(2022)
Page Start:
237
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗